Skip to main content
KALV logo

KALV

KalVista Pharmaceuticals, Inc.
$27.00 +0.00 (+0.00%) At close · Jun 12
Market Cap
$1.44B
Shares
53,240,888

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 184
Total Value: $1,446,536,628
Total Shares: 71,859,749
Showing 1–100 of 192 holdings by value · page 1 of 2

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 184 13F filers · Δ vs Dec 31, 2025
Top Holder
9.0%
Jun 2023 → Mar 2026 · range 9.0% – 13.3%
−1.0 pts
Top 5
34.2%
Jun 2023 → Mar 2026 · range 34.2% – 47.1%
−2.9 pts
Top 10
51.2%
Jun 2023 → Mar 2026 · range 51.2% – 69.6%
−5.2 pts
HHI
369
Jun 2023 → Mar 2026 · range 369 – 600
Broadly held−59

Quarterly Activity

vs Dec 31, 2025
New
39
Increased
66
Decreased
45
Sold Out
17
Unchanged
34
Holder count: +22
Institutional value: +33.5%
Shares held: +7.1%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 192
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1348911 CUSIP 483497103 Visit website Investor relations